Cargando…

The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy

SIMPLE SUMMARY: Hyperthermic intrathoracic chemotherapy (HITOC) is an intraoperative treatment after a surgical cytoreduction of pleural malignancies. The pleural cavity is perfused with high doses of cytostatic drugs that are consequentially excreted via various body fluids. These are potential occ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larisch, Christopher, Markowiak, Till, Ried, Michael, Nowak, Dennis, Hofmann, Hans-Stefan, Rakete, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571901/ https://www.ncbi.nlm.nih.gov/pubmed/37835566 http://dx.doi.org/10.3390/cancers15194872

Ejemplares similares

Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy
por: Markowiak, Till, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021)

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
por: Markowiak, Till, et al.
Publicado: (2020)

Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure
por: Larisch, Christopher, et al.
Publicado: (2021)

Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study
por: Ried, Michael, et al.
Publicado: (2023)

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
por: Ried, Michael, et al.
Publicado: (2021)

Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion
por: Kerscher, Christoph, et al.
Publicado: (2014)

Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Classification and staging of thymoma
por: Markowiak, Till, et al.
Publicado: (2020)

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Cardiac output and oxygen delivery are affected by intraoperative hyperthermic intrathoracic chemotherapy
por: Scolletta, S, et al.
Publicado: (2008)

Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
por: Ramegowda, Jalaja Koppa, et al.
Publicado: (2015)

A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
por: Song, Kimberly, et al.
Publicado: (2021)

Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021)

Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum
por: Poon, Shi Sum, et al.
Publicado: (2022)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Intraoperative Contrast-Enhanced Ultrasonography (Io-CEUS) in Minimally Invasive Thoracic Surgery for Characterization of Pulmonary Tumours: A Clinical Feasibility Study
por: Schauer, Martin Ignaz, et al.
Publicado: (2023)

Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival
por: Markowiak, Till, et al.
Publicado: (2021)

Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma
por: Branch, Kevin, et al.
Publicado: (2023)

Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion
por: Li, Zihui, et al.
Publicado: (2023)

Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
por: Zhao, Zi-Yi, et al.
Publicado: (2017)

Evaluation of Surgical Therapy in Advanced Thymic Tumors
por: Markowiak, Till, et al.
Publicado: (2021)

Short-term and long-term outcomes of intrathoracic vacuum therapy of empyema in debilitated patients
por: Sziklavari, Zsolt, et al.
Publicado: (2016)

Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis
por: Zhou, Hua, et al.
Publicado: (2017)

Postoperative outcome after palliative treatment of malignant pleural effusion
por: Markowiak, Till, et al.
Publicado: (2022)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
por: Glennon, Kate, et al.
Publicado: (2021)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy
por: Zaballos, Matilde, et al.
Publicado: (2021)

Intrathoracic aerosol chemotherapy via spray-catheter
por: Khosrawipour, Veria, et al.
Publicado: (2020)

Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer
por: Caronna, Roberto, et al.
Publicado: (2013)

Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
por: Karampinis, Ioannis, et al.
Publicado: (2022)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
por: Wang, Wu-yun, et al.
Publicado: (2021)

Hyperthermic intrapleural chemotherapy: an update
por: Campany, Megan E., et al.
Publicado: (2023)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
por: Hakeam, Hakeam, et al.
Publicado: (2019)

Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
por: Hettinga, J. V., et al.
Publicado: (1997)

Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study
por: Coccolini, Federico, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmplg30nmqe0egn96b2e2d3i5g